Proof-of-concept of a pretargeting strategy mediated by sstr2 antagonist for the therapy of neuroendocrine tumours

S. Koustoulidou; M. Handula; J. Nonnekens; M. Hendriks-de Jong; Y. Seimbille

doi:10.1007/s00259-021-05547-1

Proof-of-concept of a pretargeting strategy mediated by sstr2 antagonist for the therapy of neuroendocrine tumours

S. Koustoulidou, M. Handula, J. Nonnekens, M. Hendriks-de Jong, Y. Seimbille

Research output: Contribution to journal › Meeting Abstract › Academic › peer-review

1 Citation (Scopus)

Original language	English
Article number	OP-0552
Pages (from-to)	S193-S193
Number of pages	1
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Volume	48
Issue number	SUPPL 1
DOIs	https://doi.org/10.1007/s00259-021-05547-1
Publication status	Published - Sept 2021

Access to Document

10.1007/s00259-021-05547-1

Cite this

@article{e84415d7c87e4f67ab4a6fe9c8bebd31,

title = "Proof-of-concept of a pretargeting strategy mediated by sstr2 antagonist for the therapy of neuroendocrine tumours",

author = "S. Koustoulidou and M. Handula and J. Nonnekens and {Hendriks-de Jong}, M. and Y. Seimbille",

year = "2021",

month = sep,

doi = "10.1007/s00259-021-05547-1",

language = "English",

volume = "48",

pages = "S193--S193",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

publisher = "Springer-Verlag",

number = "SUPPL 1",

}

Proof-of-concept of a pretargeting strategy mediated by sstr2 antagonist for the therapy of neuroendocrine tumours. / Koustoulidou, S.; Handula, M.; Nonnekens, J. et al.
In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 48, No. SUPPL 1, OP-0552, 09.2021, p. S193-S193.

Research output: Contribution to journal › Meeting Abstract › Academic › peer-review

TY - JOUR

T1 - Proof-of-concept of a pretargeting strategy mediated by sstr2 antagonist for the therapy of neuroendocrine tumours

AU - Koustoulidou, S.

AU - Handula, M.

AU - Nonnekens, J.

AU - Hendriks-de Jong, M.

AU - Seimbille, Y.

PY - 2021/9

Y1 - 2021/9

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=eur_pure&SrcAuth=WosAPI&KeyUT=WOS:000709355000313&DestLinkType=FullRecord&DestApp=WOS

U2 - 10.1007/s00259-021-05547-1

DO - 10.1007/s00259-021-05547-1

M3 - Meeting Abstract

SN - 1619-7070

VL - 48

SP - S193-S193

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

IS - SUPPL 1

M1 - OP-0552

ER -

Proof-of-concept of a pretargeting strategy mediated by sstr2 antagonist for the therapy of neuroendocrine tumours

Access to Document

Other files and links

Cite this